Identification and regulation of bone morphogenetic protein antagonists associated with preantral follicle development in the ovary

Endocrinology

Volumn 152, Issue 9, 2011, Pages 3515-3526

  Fenwick, Mark A ^a   Mansour, Yosef T ^a   Franks, Stephen ^a   Hardy, Kate ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BMPER PROTEIN; BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN ANTAGONIST; CHRD PROTEIN; CYTOKINE RECEPTOR ANTAGONIST; FST PROTEIN; HTRA1 PROTEIN; NBL1 PROTEIN; NOG PROTEIN; SOSTDC1 PROTEIN; TWISTED GASTRULATION HOMOLOG 1 PROTEIN; UNCLASSIFIED DRUG; VWC2 PROTEIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG IDENTIFICATION; FEMALE; GASTRULATION; GENE EXPRESSION; GENE LOCATION; GENETIC TRANSCRIPTION; GRANULOSA CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; MOUSE; NEWBORN; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PARACRINE SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION; MICE; OVARIAN FOLLICLE; OVARY; PARACRINE COMMUNICATION;

EID: 80052438226     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-0229     Document Type: Article

References (65)

1. Knight PG, Glister C 2006 TGF-β superfamily members and ovarian follicle development. Reproduction 132:191-206
2. Mazerbourg S, Hsueh AJ 2006 Genomic analyses facilitate identification of receptors and signalling pathways for growth differentiation factor 9 and related orphan bone morphogenetic protein/growth differentiation factor ligands. Hum Reprod Update 12:373-383
3. Dube JL, Wang P, Elvin J, Lyons KM, Celeste AJ, Matzuk MM 1998 The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol Endocrinol 12:1809-1817
4. Elvin JA, Yan C, Matzuk MM 2000 Oocyte-expressed TGF-β superfamily members in female fertility. Mol Cell Endocrinol 159:1-5
5. McGrath SA, Esquela AF, Lee SJ 1995 Oocyte-specific expression of growth/differentiation factor-9. Mol Endocrinol 9:131-136
6. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP 2002 Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076-1084
7. Erickson GF, Shimasaki S 2003 The spatiotemporal expression pattern of the bone morphogenetic protein family in rat ovary cell types during the estrous cycle. Reprod Biol Endocrinol 1:9
8. Pierre A, Pisselet C, Dupont J, Bontoux M, Monget P 2005 Bone morphogenetic protein 5 expression in the rat ovary: biological effects on granulosa cell proliferation and steroidogenesis. Biol Reprod 73:1102-1108
9. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282-7287
10. Souza CJ, Campbell BK, McNeilly AS, Baird DT 2002 Effect of bone morphogenetic protein 2 (BMP2) on oestradiol and inhibin A production by sheep granulosa cells, and localization of BMP receptors in the ovary by immunohistochemistry. Reproduction 123:363-369
11. Bicsak TA, Tucker EM, Cappel S, Vaughan J, Rivier J, Vale W, Hsueh AJ 1986 Hormonal regulation of granulosa cell inhibin biosynthesis. Endocrinology 119:2711-2719
12. Guéripel X, Brun V, Gougeon A 2006 Oocyte bone morphogenetic protein 15, but not growth differentiation factor 9, is increased during gonadotropin-induced follicular development in the immature mouse and is associated with cumulus oophorus expansion. Biol Reprod 75:836-843
13. Kobayashi N, Orisaka M, Cao M, Kotsuji F, Leader A, Sakuragi N, Tsang BK 2009 Growth differentiation factor-9 mediates follicle-stimulating hormone-thyroid hormone interaction in the regulation of rat preantral follicular development. Endocrinology 150:5566-5574
14. Mulheron GW, Danielpour D, Schomberg DW 1991 Rat thecal/interstitial cells express transforming growth factor-β type 1 and 2, but only type 2 is regulated by gonadotropin in vitro. Endocrinology 129:368-374
15. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383:531-535
16. Elvin JA, Yan C, Wang P, Nishimori K, Matzuk MM 1999 Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018-1034
17. Galloway SM, McNatty KP, Cambridge LM, Laitinen MP, Juengel JL, Jokiranta TS, McLaren RJ, Luiro K, Dodds KG, Montgomery GW, Beattie AE, Davis GH, Ritvos O 2000 Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 25:279-283
18. Edson MA, Nalam RL, Clementi C, Franco HL, Demayo FJ, Lyons KM, Pangas SA, Matzuk MM 2010 Granulosa cell-expressed BMPR1Aand BMPR1B have unique functions in regulating fertility but act redundantly to suppress ovarian tumor development. Mol Endocrinol 24:1251-1266
19. Pangas SA, Li X, Umans L, Zwijsen A, Huylebroeck D, Gutierrez C, Wang D, Martin JF, Jamin SP, Behringer RR, Robertson EJ, Matzuk MM 2008 Conditional deletion of Smad1 and Smad5 in somatic cells of male and female gonads leads to metastatic tumor development in mice. Mol Cell Biol 28:248-257
20. Li Q, Pangas SA, Jorgez CJ, Graff JM, Weinstein M, Matzuk MM 2008 Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol 28:7001-7011
21. Lee WS, Otsuka F, Moore RK, Shimasaki S 2001 Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 65:994-999
22. Tanwar PS, O'Shea T, McFarlane JR 2008 In vivo evidence of role of bone morphogenetic protein-4 in the mouse ovary. Anim Reprod Sci 106:232-240
23. Nilsson EE, Skinner MK 2003 Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 69:1265-1272
24. De Robertis EM 2009 Spemann's organizer and the self-regulation of embryonic fields. Mech Dev 126:925-941
25. Zakin L, De Robertis EM 2010 Extracellular regulation of BMP signaling. Curr Biol 20:R89-R92
26. Reversade B, De Robertis EM 2005 Regulation of ADMP and BMP2/4/7 at opposite embryonic poles generates a self-regulating morphogenetic field. Cell 123:1147-1160
27. Gazzerro E, Canalis E 2006 Bone morphogenetic proteins and their antagonists. Rev Endocr Metab Disord 7:51-65
28. Avsian-Kretchmer O, Hsueh AJ 2004 Comparative genomic analysis of the eight-membered ring cystine knot-containing bone morphogenetic protein antagonists. Mol Endocrinol 18:1-12
29. Piccolo S, Sasai Y, Lu B, De Robertis EM 1996 Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4. Cell 86:589-598
30. Pangas SA, Jorgez CJ, Matzuk MM 2004 Growth differentiation factor 9 regulates expression of the bone morphogenetic protein antagonist gremlin. J Biol Chem 279:32281-32286
31. Sudo S, Avsian-Kretchmer O, Wang LS, Hsueh AJ 2004 Protein related to DAN and cerberus is a bone morphogenetic protein antagonist that participates in ovarian paracrine regulation. J Biol Chem 279:23134-23141
32. Glister C, Richards SL, Knight PG 2005 Bone morphogenetic proteins (BMP) -4, -6, and -7 potently suppress basal and luteinizing hormone-induced androgen production by bovine theca interna cells in primary culture: could ovarian hyperandrogenic dysfunction be caused by a defect in thecal BMP signaling? Endocrinology 146:1883-1892
33. Pierre A, Pisselet C, Monget P, Monniaux D, Fabre S 2005 Testing the antagonistic effect of follistatin on BMP family members in ovine granulosa cells. Reprod Nutr Dev 45:419-425
34. Sugiura K, Su YQ, Li Q, Wigglesworth K, Matzuk MM, Eppig JJ 2009 Fibroblast growth factors and epidermal growth factor cooperate with oocyte-derived members of the TGFβ superfamily to regulate Spry2 mRNA levels in mouse cumulus cells. Biol Reprod 81:833-841
35. Edson MA, Nagaraja AK, Matzuk MM 2009 The mammalian ovary from genesis to revelation. Endocr Rev 30:624-712
36. Da Silva-Buttkus P, Marcelli G, Franks S, Stark J, Hardy K 2009 Inferring biological mechanisms from spatial analysis: prediction of a local inhibitor in the ovary. Proc Natl Acad Sci USA 106:456-461
37. Dionne MS, Skarnes WC, Harland RM 2001 Mutation and analysis of Dan, the founding member of the Dan family of transforming growth factor β antagonists. Mol Cell Biol 21:636-643
38. Iemura S, Yamamoto TS, Takagi C, Uchiyama H, Natsume T, Shimasaki S, Sugino H, Ueno N 1998 Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. Proc Natl Acad Sci USA 95:9337-9342
39. Oelgeschläger M, Larraín J, Geissert D, De Robertis EM 2000 The evolutionarily conserved BMP-binding protein Twisted gastrulation promotes BMP signalling. Nature 405:757-763
40. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M 2004 HtrA1 serine protease inhibits signaling mediated by Tgfβ family proteins. Development 131:1041-1053
41. Chang C, Holtzman DA, Chau S, Chickering T, Woolf EA, Holmgren LM, Bodorova J, Gearing DP, Holmes WE, Brivanlou AH 2001 Twisted gastrulation can function as a BMP antagonist. Nature 410:483-487
42. Scott IC, Blitz IL, Pappano WN, Maas SA, Cho KW, Greenspan DS 2001 Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP signalling. Nature 410:475-478
43. Zakin L, Chang EY, Plouhinec JL, De Robertis EM 2010 Cross-veinless-2 is required for the relocalization of Chordin protein within the vertebral field in mouse embryos. Dev Biol 347:204-215
44. Tocharus J, Tsuchiya A, Kajikawa M, Ueta Y, Oka C, Kawaichi M 2004 Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-β signaling. Dev Growth Differ 46:257-274
45. Wahlberg P, Nylander A, Ahlskog N, Liu K, Ny T 2008 Expression and localization of the serine proteases high-temperature requirement factor A1, serine protease 23, and serine protease 35 in the mouse ovary. Endocrinology 149:5070-5077
46. Hou J, Clemmons DR, Smeekens S 2005 Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5. J Cell Biochem 94:470-484
47. Otsuka F, Moore RK, Iemura S, Ueno N, Shimasaki S 2001 Follistatin inhibits the function of the oocyte-derived factor BMP-15. Biochem Biophys Res Commun 289:961-966
48. Nakatani A, Shimasaki S, Depaolo LV, Erickson GF, Ling N 1991 Cyclic changes in follistatin messenger ribonucleic acid and its protein in the rat ovary during the estrous cycle. Endocrinology 129:603-611
49. Roberts VJ, Barth S, el-Roeiy A, Yen SS 1993 Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J Clin Endocrinol Metab 77:1402-1410
50. Shimasaki S, Koga M, Buscaglia ML, Simmons DM, Bicsak TA, Ling N 1989 Follistatin gene expression in the ovary and extragonadal tissues. Mol Endocrinol 3:651-659
51. Fazzini M, Vallejo G, Colman-Lerner A, Trigo R, Campo S, Barañao JL, Saragüeta PE 2006 Transforming growth factor β1 regulates follistatin mRNA expression during in vitro bovine granulosa cell differentiation. J Cell Physiol 207:40-48
52. Shintani Y, Dyson M, Drummond AE, Findlay JK 1997 Regulation of follistatin production by rat granulosa cells in vitro. Endocrinology 138:2544-2551
53. Tano M, Minegishi T, Nakamura K, Nakamura M, Karino S, Miyamoto K, Ibuki Y 1995 Regulation of follistatin messenger ribonucleic acid in cultured rat granulosa cells. Mol Cell Endocrinol 109:167-174
54. Yao HH, Matzuk MM, Jorgez CJ, Menke DB, Page DC, Swain A, Capel B 2004 Follistatin operates downstream of Wnt4 in mammalian ovary organogenesis. Dev Dyn 230:210-215
55. Stanley E, Biben C, Kotecha S, Fabri L, Tajbakhsh S, Wang CC, Hatzistavrou T, Roberts B, Drinkwater C, Lah M, Buckingham M, Hilton D, Nash A, Mohun T, Harvey RP 1998 DAN is a secreted glycoprotein related to Xenopus cerberus. Mech Dev 77:173-184
56. Harlow CR, Davidson L, Burns KH, Yan C, Matzuk MM, Hillier SG 2002 FSH and TGF-β superfamily members regulate granulosa cell connective tissue growth factor gene expression in vitro and in vivo. Endocrinology 143:3316-3325
57. Abreu JG, Ketpura NI, Reversade B, De Robertis EM 2002 Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-β. Nat Cell Biol 4:599-604
58. Harlow CR, Bradshaw AC, Rae MT, Shearer KD, Hillier SG 2007 Oestrogen formation and connective tissue growth factor expression in rat granulosa cells. J Endocrinol 192:41-52
59. Zimmerman LB, De Jesús-Escobar JM, Harland RM 1996 The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86:599-606
60. Belo JA, Bachiller D, Agius E, Kemp C, Borges AC, Marques S, Piccolo S, De Robertis EM 2000 Cerberus-like is a secreted BMP and nodal antagonist not essential for mouse development. Genesis 26:265-270
61. Yanagita M, Okuda T, Endo S, Tanaka M, Takahashi K, Sugiyama F, Kunita S, Takahashi S, Fukatsu A, Yanagisawa M, Kita T, Sakurai T 2006 Uterine sensitization-associated gene-1 (USAG-1), a novel BMP antagonist expressed in the kidney, accelerates tubular injury. J Clin Invest 116:70-79
62. Kosaki K, Sato S, Hasegawa T, Matsuo N, Suzuki T, Ogata T 2004 Premature ovarian failure in a female with proximal symphalangism and Noggin mutation. Fertil Steril 81:1137-1139
63. Millet C, Lemaire P, Orsetti B, Guglielmi P, François V 2001 The human chordin gene encodes several differentially expressed spliced variants with distinct BMP opposing activities. Mech Dev 106:85-96
64. Balemans W, Van Hul W 2002 Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev Biol 250:231-250
65. Juengel JL, Reader KL, Bibby AH, Lun S, Ross I, Haydon LJ, McNatty KP 2006 The role of bone morphogenetic proteins 2, 4, 6 and 7 during ovarian follicular development in sheep: contrast to rat. Reproduction 131:501-513